Integer (NYSE:ITGR) Sets New 1-Year High – Still a Buy?

Posted by Geri Gentry on Aug 8th, 2026

Integer Holdings Corporation (NYSE:ITGR – Get Free Report) shares hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $126.14 and last traded at $125.5720, with a volume of 1658621 shares traded. The stock had previously closed at $125.00.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Monday. Citigroup raised their price target on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday. Finally, Zacks Research raised Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, Integer has a consensus rating of “Hold” and a consensus price target of $109.86.

Get Our Latest Research Report on ITGR

Integer Price Performance

The business has a 50 day moving average price of $97.41 and a 200-day moving average price of $90.37. The company has a market capitalization of $4.25 billion, a price-to-earnings ratio of 34.17, a P/E/G ratio of 3.00 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.38 and a current ratio of 3.73.

Integer (NYSE:ITGR – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same period in the prior year, the business earned $1.55 EPS. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. Research analysts predict that Integer Holdings Corporation will post 6.04 EPS for the current fiscal year.

Institutional Trading of Integer

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after acquiring an additional 837 shares in the last quarter. Millennium Management LLC raised its holdings in Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after buying an additional 7,190 shares in the last quarter. United Services Automobile Association acquired a new position in shares of Integer during the first quarter valued at about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Integer by 4.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after acquiring an additional 4,873 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

About Integer

(Get Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.